Business Wire

Azizi Developments Unveils Azizi Milan, the New Fashion Capital of the Middle East

23.4.2025 09:00:00 CEST | Business Wire | Press Release

Share

Azizi Developments, a leading private developer in the UAE, has unveiled Azizi Milan, a landmark master-planned community, guided by the principles of sustainability, nature, and the cultured refinement of Italian fashion, that is set to bring the timeless Milanese charm to Dubai. The launch event, which will welcome over 10,000 guests, is hosted on April 23rd, 2025, in Dubai’s renowned Coca-Cola Arena, featuring headlining performances by Tamer Hosny, Nora Fatehi and Sunidhi Chauhan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423689949/en/

Azizi Milan, the new fashion capital of the Middle East (Photo: AETOSWire)

Azizi Milan, at a total value exceeding AED 75 billion, is slated to cover 40,350,000 sq. ft.,making it one of the largest mixed-use communities in the entire UAE. The master plan will be home to a population of 144,000, with 800 hotel keys to be created.

Mr. Mirwais Azizi, Founder and Chairman of Azizi Developments, said: "Much like the famed city of Milan, known for its beauty and elegance, Azizi Milan will embody the spirit of Italian living, right here in our home - Dubai. We have put a lot of thought into every detail, thinking about public spaces and community areas as well as creating homes that are as sophisticated and sustainable as they are welcoming. As with our other major projects, we are committed to building world-class homes and infrastructure that elevate the lifestyles of all those who will visit, live and work in what will soon be the classy, tasteful, and sustainable fashion capital of the Middle East. It is His Highness Sheikh Mohammed bin Rashid Al Maktoum UAE Vice President, Prime Minister and Ruler of Dubai, who through his unparalleled visionary leadership has nurtured the emirate into the high-in-demand city that it is today, and it is with pride that we will help satiate that demand with our largest-yet community, Azizi Milan.”

Azizi Milan has been conceptualized with inspiration from Milan's rich cultural heritage. Its bold arches and design elements add to aesthetics as well as function. The community embodies Italian sophistication, inviting future homeowners to immerse themselves in a lifestyle centered around living life to the fullest, where the beauty of everyday moments and simple pleasures are truly appreciated. Azizi Milan is poised to become the fashion capital of the region with its very own network of pedestrian-only fashion streets – each dedicated to their own realm of fashion, including one for perfumery, one for cosmetics, and more for bags, dress fashion, and beyond. Lined with an ample number of high-fashion brands and boutique shops, as well as numerous cafes, fine-dining restaurants, and nightlife entertainment options, Azizi A will form a focal point for those who enjoy the city’s vibrant after-hours, as well as for those wanting to be part of internationally acclaimed fashion shows and other high-caliber events that will be hosted there.

Sustainability is a key consideration that guides the entire development of this contemporary zero-carbon community. To offset emissions, Azizi will support the landmark mangrove carbon project, as well as global forest and solar developments certified by VERRA and the Gold Standard. Next to a wide plethora of green building practices being implemented, every single building will feature its own beautifully landscaped rooftop garden, with the entirety of all roofs, as well as all podiums and a vast number of dedicated areas surrounding the residences, being planted with exotic trees and flowers. Infinity pools will be framed by lush, meticulously manicured greenery. Through the panoramic elevators that form an awe-inspiring feat of architecture in each and every building, residents and visitors are granted all-encompassing, scenic views of the community’s stunning nature, its many fountains and water features, and its wide array of sports courts and other facilities that will enrich lives and foster a sense of community and belonging.

Azizi Milan is a dynamic, self-sustaining haven with residential projects, a sprawling mall, luxury hotels, retail districts, office spaces, and essential lifestyle amenities, including schools, nurseries, mosques, wellness facilities, and parks. Its tallest towers, which will shape the northern skyline, will rise up to 70 stories high, while low- to mid-rises from 25 to 35 stories make up the central part of the development, easing the shift into a quieter, more tranquil residential atmosphere.

Strategically situated ion the iconic Sheikh Mohammed Bin Zayed Road (E311) – one of the UAE’s most important arteries that connects Abu Dhabi, Dubai, Sharjah, Ajman and Ras Al Khaimah – Azizi Milan offers unmatched accessibility. Adding to its location’s appeal, the community is just a short, less-than-5-minute walk from the nearest future Blue Line metro station.

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20250423689949/en/

Contacts

For further information about Azizi Developments:

Tizian H. G. Raab
Head of PR & Communications
M: +971558673606
Email: tizian@azizidevelopments.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye